[go: up one dir, main page]

WO2008118469A3 - Genetics variants associated with hiv disease restriction - Google Patents

Genetics variants associated with hiv disease restriction Download PDF

Info

Publication number
WO2008118469A3
WO2008118469A3 PCT/US2008/003964 US2008003964W WO2008118469A3 WO 2008118469 A3 WO2008118469 A3 WO 2008118469A3 US 2008003964 W US2008003964 W US 2008003964W WO 2008118469 A3 WO2008118469 A3 WO 2008118469A3
Authority
WO
WIPO (PCT)
Prior art keywords
variants associated
hiv disease
restriction
genetics
genetics variants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/003964
Other languages
French (fr)
Other versions
WO2008118469A2 (en
Inventor
David B Goldstein
Amalio Telenti
Jacques Fellay
Kevin V Shianna
Dongliang Ge
Barton F Haynes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Lausanne
Duke University
Original Assignee
Universite de Lausanne
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Lausanne, Duke University filed Critical Universite de Lausanne
Priority to CA002680834A priority Critical patent/CA2680834A1/en
Priority to JP2010500973A priority patent/JP2010522560A/en
Priority to EP08727164A priority patent/EP2121985A4/en
Priority to AU2008231305A priority patent/AU2008231305A1/en
Publication of WO2008118469A2 publication Critical patent/WO2008118469A2/en
Publication of WO2008118469A3 publication Critical patent/WO2008118469A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • AIDS & HIV (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates, in general, to human immunodeficiency virus (HIV) and, in particular, to genetic variants associated with restriction of HIV disease progression.
PCT/US2008/003964 2007-03-27 2008-03-27 Genetics variants associated with hiv disease restriction Ceased WO2008118469A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002680834A CA2680834A1 (en) 2007-03-27 2008-03-27 Genetics variants associated with hiv disease restriction
JP2010500973A JP2010522560A (en) 2007-03-27 2008-03-27 Genetic variants associated with HIV disease restriction
EP08727164A EP2121985A4 (en) 2007-03-27 2008-03-27 GENETIC VARIANTS ASSOCIATED WITH RESTRICTION OF HIV DISEASE
AU2008231305A AU2008231305A1 (en) 2007-03-27 2008-03-27 Genetics variants associated with HIV disease restriction

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US90727107P 2007-03-27 2007-03-27
US60/907,271 2007-03-27
US92943207P 2007-06-27 2007-06-27
US60/929,432 2007-06-27

Publications (2)

Publication Number Publication Date
WO2008118469A2 WO2008118469A2 (en) 2008-10-02
WO2008118469A3 true WO2008118469A3 (en) 2008-12-24

Family

ID=39789200

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/003964 Ceased WO2008118469A2 (en) 2007-03-27 2008-03-27 Genetics variants associated with hiv disease restriction

Country Status (5)

Country Link
EP (1) EP2121985A4 (en)
JP (1) JP2010522560A (en)
AU (1) AU2008231305A1 (en)
CA (1) CA2680834A1 (en)
WO (1) WO2008118469A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105316417B (en) * 2015-11-27 2018-11-30 北京泱深生物信息技术有限公司 The diagnosis and treatment target of ZNRD1 gene and its expression product as intracranial aneurysm
RU2761249C2 (en) * 2016-12-14 2021-12-06 Мерк Шарп энд Доум Корп. Human genetic markers associated with response to treatment agents that target toxin b clostridium difficile

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006130152A2 (en) * 2004-11-26 2006-12-07 Board Of Regents, University Of Texas System Methods and compositions for correlating ccl3l1/ccr5 genotypes with disorders

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FELLAY ET AL.: "A whole-genome association study of major determinant for host control of HIV-1", SCIENCE, vol. 317, no. 5840, August 2007 (2007-08-01), pages 944 - 947, XP002551832 *
See also references of EP2121985A4 *

Also Published As

Publication number Publication date
JP2010522560A (en) 2010-07-08
AU2008231305A1 (en) 2008-10-02
CA2680834A1 (en) 2008-10-02
WO2008118469A2 (en) 2008-10-02
EP2121985A2 (en) 2009-11-25
EP2121985A4 (en) 2011-01-05

Similar Documents

Publication Publication Date Title
IL281111A (en) Compositions for conferring tolerance to viral disease in social insects, and the use thereof
USD624989S1 (en) Single-handle deck-mount faucet
USD660054S1 (en) Seating unit
USD625507S1 (en) Folding canopy
WO2008045238A3 (en) Stabilized therapeutic small helical antiviral peptides
PT1848837E (en) Improved glass stability, glass forming ability, and microstructural refinement
WO2011012316A3 (en) Rna with a combination of unmodified and modified nucleotides for protein expression
WO2008014200A3 (en) Cyclosporin compositions
USD697565S1 (en) Physical exerciser
WO2008151032A3 (en) Arrays and methods comprising m. smithii gene products
USD644455S1 (en) Table
WO2011049914A3 (en) Anti-hiv peptides and methods of use thereof
WO2008088747A3 (en) Method of monitoring hiv infection
WO2009099467A3 (en) Cyclosporin compositions
USD652757S1 (en) Variable neckwear with ornamental ends
USD687556S1 (en) BOXER'S fracture brace
USD675397S1 (en) Pair of sleeves
WO2012037116A3 (en) Genetic variations associated with common variable immunodeficiency (cvid) and methods of use thereof
WO2010064822A2 (en) Effective control of viral plant disease with strains of pseudomonas oleovorans
WO2008033500A3 (en) Carbohydrate-based vaccines for hiv
USD628895S1 (en) Bottle
WO2008118469A3 (en) Genetics variants associated with hiv disease restriction
WO2009128911A3 (en) Genetics variants associated with hiv disease restriction
WO2008152252A3 (en) Rumc peptides with antimicrobial activity
WO2008108660A3 (en) Fish disease detection

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08727164

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
ENP Entry into the national phase

Ref document number: 2680834

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2010500973

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2008727164

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008231305

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2008231305

Country of ref document: AU

Date of ref document: 20080327

Kind code of ref document: A

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)